Indrayani Biotech Limited (BOM:526445)
7.94
-0.04 (-0.50%)
At close: Aug 28, 2026
Indrayani Biotech Revenue
In the fiscal year ending March 31, 2026, Indrayani Biotech had annual revenue of 1.38B INR with 5.84% growth. Indrayani Biotech had revenue of 727.79M in the quarter ending March 31, 2026, with 36.43% growth.
Revenue
1.38B
Revenue Growth
+3.36%
P/S Ratio
0.26
Revenue / Employee
1.47M
Employees
936
Market Cap
361.56M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.38B | 76.03M | 5.84% |
| Mar 31, 2025 | 1.30B | -359.97M | -21.66% |
| Mar 31, 2024 | 1.66B | 32.96M | 2.02% |
| Mar 31, 2023 | 1.63B | 1.01B | 164.57% |
| Mar 31, 2022 | 615.82M | 403.91M | 190.60% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Stanbik Agro | 858.95M |
| Raminfo | 559.12M |
| Kalyan Capitals | 386.30M |
| Morarjee Textiles | 328.30M |
| Glance Finance | 201.22M |
| Jay Kailash Namkeen | 174.62M |
| Anupam Finserv | 53.85M |
| Sanwaria Consumer | 10.72M |